OXFORD, England ,
May 14,
2024 /PRNewswire/ -- Oxehealth, the global leader in
intelligent patient monitoring for acute mental health, has
announced FDA and EU clearances of new sleep monitoring software,
extending the scope of its contactless patient monitoring
platform.
The technology is the latest breakthrough medical device
launched by Oxehealth, It assesses patients' sleep/wake patterns
with a level of accuracy comparable to polysomnography and provides
automated daily outputs which healthcare staff can use to support
clinical decision-making.
Given the proven links between sleep and mental health, sleep
insights should be a key part of providing the best care and
treatment. But until now, obtaining objective and accurate sleep
data in acute mental health has been a challenge.
"In inpatient psychiatric settings it is impractical and
unsafe to attach standard polysomnography equipment to
patients," said Dr. Michael Geonevese. "Oxehealth's novel
solution has such huge potential. The insights it provides can
support clinical teams to tailor their care plans and promote
recovery. Ultimately it could even allow clinical teams to refine
medication prescriptions and optimize length of stay."
Todd Haedrich, CEO of Oxehealth,
commented, "We are excited to announce our latest world-first
breakthrough. We are now actively seeking acute mental health
providers, who are forward thinking and interested in leveraging
technology to advance their capabilities, to join our new Innovator
Program."
About Oxehealth
Oxehealth is the global leader in intelligent patient monitoring
for acute mental health. The company is dedicated to helping
clinical staff deliver safer, higher-quality and more efficient
inpatient care. Oxehealth partners with half of NHS England's
mental health providers and is expanding to transform inpatient
care in the US and Europe. For
more information, visit www.oxehealth.com.
About Oxevision
Oxevision is a contactless patient monitoring platform for acute
mental health. It consists of camera-based hardware and a suite of
software modules including FDA-cleared and CE-marked medical
devices for vital signs and sleep monitoring. Oxevision improves
the ability of clinical teams to observe patients, intervene when
necessary and plan care effectively. Providers that give their
staff Oxevision are proven to deliver safer, higher-quality and
more efficient care. For more information, visit
www.oxehealth.com/oxevision.
For further information visit:
www.oxehealth.com
For media enquiries contact:
Ben Walsh; +44 (0)7554
018066; ben.walsh@oxehealth.com
For investor enquiries contact:
Tom Hatfield; tom.hatfield@oxehealth.com
For sales enquiries contact:
Todd
Haedrich; todd.haedrich@oxehealth.com
Register interest:
Innovator Program
Photo -
https://mma.prnewswire.com/media/2412371/Oxehealth.jpg
View original content to download
multimedia:https://www.prnewswire.com/news-releases/oxehealth-granted-regulatory-clearances-for-mental-health-sleep-monitoring-302145051.html
SOURCE Oxehealth